Sign In
Last checked at 
29 Aug 2013 16:49
ORYX INTERNATIONAL GROWTH FUND LIMITED
INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2013
Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FCA Handbook.
This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.
This interim management statement relates to the period from 1 April 2013 to 30 June 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.
Manager's Review
During the period under review, the FTSE Small Cap Index returned 2.6% and the FTSE All-Share Index returned -3.3%. Against this, the Company's net asset value rose by 1.9% to 385p per share. The Company has benefited from the recent improvement in market conditions and we are pleased to report that the net asset value per share has reached an all-time high.
As reported previously, a number of the companies in the Unquoted portfolio are in the process of corporate activity. Since the end of the period under review, Bionostics has, in fact, been sold and the sale proceeds have been received.
Material Transactions
During the quarter ended 30 June 2013, the Company purchased 78,488 numbers of shares for the purposes of cancellation.
Material Events
There were no material events during the quarter ended 30 June 2013.
Report and Accounts
On 18 July 2013, the Company released its Annual Report and Condensed Consolidated Financial Statements for the year ended 31 March 2013, to Shareholders.
Financial Highlights
| 30 June 2013 | 31 March 2013 | 31 December 2012 | 30 September 2012 | 30 June 2012 |
|
|
|
|
|
|
NAV | £3.85 | £3.78 | £3.48 | £3.22 | £2.93 |
|
|
|
|
|
|
US Dollar / Sterling Exchange Rate |
1.516744 |
1.518218 |
1.6254 |
1.6148 |
1.5685 |
|
|
|
|
|
|
Twenty Largest Equity Investments at 30 June 2013
DETAILS | % NET ASSETS |
NASTOR INV LTD ZERO REDEEM PREFER SHARES | 1.00 |
MECOM GROUP PLC | 2.00 |
SINAV LIMTED | 2.00 |
TEAM ROCK PREFERENCE GBP SHARES | 2.00 |
AUGEAN PLC | 3.00 |
ECKOH PLC | 3.00 |
BIONOSTICS HOLDINGS LTD | 4.00 |
CELSIS AG | 4.00 |
GUINNESS PEAT GROUP PLC | 5.00 |
IFG GROUP PLC | 5.00 |
JOURNEY GROUP PLC | 5.00 |
ORTHOPRODUCTS LTD | 5.00 |
CATALYST MEDIA GROUP PLC | 5.00 |
CVS GROUP PLC | 5.00 |
CYPROTEX PLC | 5.00 |
ASSETCO PLC | 5.00 |
BIOQUELL PLC | 6.00 |
QUARTO GROUP INC | 6.00 |
GOALS SOCCER CENTRES PLC | 7.00 |
GLEESON (M.J.) GROUP PLC | 14.00 |
TOTAL | 94.00 |
The financial information for the quarter ended 30 June 2013 contained within this Interim Management Statement has not been audited.
By order of the Board
BNP Paribas Securities Services S.C.A., Guernsey Branch , for and on behalf of
Oryx International Growth Fund Limited
as Company Secretary
Follow the stocks
